The Recall Desk
Agency classClass IOur severity:SevereFDA (Devices)·Z-1490-2023·Announced 2023-05-17

ANGIOGUARD RX/XP Emboli Capture Guidewire System May Separate During Procedures

ANGIOGUARD RX/XP emboli capture guidewire systems may separate from their delivery sheaths during interventional procedures, potentially causing stroke. Cordis is recalling 56 units distributed worldwide.

The agency’s classification

FDA (Devices): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: FDA Class I recall classification requires minimum severity of 4. Device may separate during critical vascular procedures, creating potential for stroke. No reported cases of injury or death at the time of recall, preventing a Critical rating.

Plain-English summary

ANGIOGUARD RX/XP Emboli Capture Guidewire System (Model REF 401814RM) is being recalled by Cordis US Corp. Fifty-six units have been distributed worldwide.

The delivery system and capture sheath of this device may separate during vascular procedures, including situations involving intra-procedural delays, unplanned percutaneous intervention, or unplanned surgical intervention while a replacement device is being prepared. This separation poses a risk of stroke.

Healthcare providers using this device should cease use and contact Cordis US Corp for guidance on device return or replacement. Patients who have undergone procedures with this device should consult their healthcare provider if they experience symptoms of stroke, such as sudden weakness, numbness, difficulty speaking, or facial drooping.

The recalled product

Product
ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 401814RM
Manufacturer
Cordis US Corp
Affected units
56

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • UDI/DI 20705032053492
  • Lot Numbers: 35265339
  • 35265670

Distribution

Distribution scope not specified by the agency.

Part of a larger recall action

This product is one of 14 recalled by Cordis US Corp under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 14 products in this recall →

Similar recalls